Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999

被引:121
作者
Thorpe, LE
Ouellet, LJ
Levy, JR
Williams, IT
Monterroso, ER
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Hepatitis Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[3] Univ Illinois, Dept Epidemiol & Biostat, Chicago, IL USA
关键词
D O I
10.1086/317607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence, risk factors, and prevention opportunities of hepatitis C virus (HCV) infection were studied in a large sample of 698 young adult injection drug users (IDUs) in Chicago, 18-30 years old. Participants were recruited between 1997 and 1999 by using street outreach, targeted advertising, and chain-referral methods. HCV infection prevalence was 27% and was strongly associated with both age and duration of injecting (P < .001), In multivariable analysis, sexual behaviors were unrelated to seropositivity, Independent drug-related risk factors included frequent injection, heavy crack smoking, injecting in a shooting gallery, and syringe-mediated sharing. Urban residents were more likely than suburban residents to be infected. Most research on hepatitis C has shown rapid spread of infection among IDUs, but these findings underscore that opportunities to identify IDUs uninfected with HCV may be greater than assumed and emphasize the need to target younger, newer IDUs.
引用
收藏
页码:1588 / 1594
页数:7
相关论文
共 23 条
[1]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[2]   The importance of preventing hepatitis C virus infection among injection drug users in the United States [J].
Alter, MJ ;
Moyer, LA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 :S6-S10
[3]  
*CDCP, 1998, MMWR-MORBID MORTAL W, V147, P1
[4]   Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995 [J].
Crofts, N ;
Aitken, CK .
MEDICAL JOURNAL OF AUSTRALIA, 1997, 167 (01) :17-20
[5]   Epidemiology of hepatitis C virus infection among injecting drug users in Australia [J].
Crofts, N ;
Jolley, D ;
Kaldor, J ;
van Beek, I ;
Wodak, A .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1997, 51 (06) :692-697
[6]  
DIAZ S, 1999, 127 ANN M AM PUBL HL
[7]   ANTIBODY TO HEPATITIS-C VIRUS AMONG CARDIAC-SURGERY PATIENTS, HOMOSEXUAL MEN, AND INTRAVENOUS-DRUG-USERS IN BALTIMORE, MARYLAND [J].
DONAHUE, JG ;
NELSON, KE ;
MUNOZ, A ;
VLAHOV, D ;
RENNIE, LL ;
TAYLOR, EL ;
SAAH, AJ ;
COHN, S ;
ODAKA, NJ ;
FARZADEGAN, H .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (10) :1206-1211
[8]   Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses [J].
Garfein, RS ;
Vlahov, D ;
Galai, N ;
Doherty, MC ;
Nelson, KE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) :655-661
[9]   Prevalence and incidence of hepatitis C virus infection among young adult injection drug users [J].
Garfein, RS ;
Doherty, MC ;
Monterroso, ER ;
Thomas, DL ;
Nelson, KE ;
Vlahov, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 :S11-S19
[10]  
Hagan H, 1999, AM J EPIDEMIOL, V149, P203, DOI 10.1093/oxfordjournals.aje.a009792